SC
DVAX

Syon Capital’s Dynavax Technologies DVAX Stock Holding History

Syon Capital’s Portfolio DVAX Stock Details DVAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-25,565
Closed -$332K – 743
2025
Q1 		$332K Sell
25,565
-1,008
-4% -$13.3K 0.03% 395
2024
Q4 		$339K Buy
+26,573
New +$321K 0.03% 369

Other funds holding DVAX

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Syon Capital's DVAX Position: Q2 2025 in Review

Syon Capital sold out of Dynavax Technologies (DVAX) in Q2 2025, closing a stake of 25,565 shares — an estimated $332K sold.

Syon Capital first reported a position in DVAX in Q4 2024 and held it in 2 quarters. The position peaked at $339K in Q4 2024. 268 funds tracked by Wall St. Rank hold DVAX as of Q2 2025.

  • Syon Capital reported no remaining Dynavax Technologies position as of Q2 2025 after selling out during the quarter.
  • Syon Capital sold 25,565 Dynavax Technologies shares in Q2 2025, an estimated $332K.
  • Syon Capital first reported a position in Dynavax Technologies in Q4 2024 and held it in 2 quarters.
  • Syon Capital's Dynavax Technologies position peaked at $339K in Q4 2024.
  • 268 funds tracked by Wall St. Rank held Dynavax Technologies as of Q2 2025.

Based on Syon Capital's 13F filing for Q2 2025, filed 14 Aug 2025.